Loading resource…

University of Münster, European Foundation for Study of Chronic Liver Failure, University of Southern Denmark, Yale University, VA-CT Healthcare System
Albumin is a crucial protein synthesized by the liver, and its levels are often reduced in liver diseases such as cirrhosis. The document explores the pathophysiological relevance of intravenous albumin administration, particularly in advanced cirrhosis, and raises critical questions regarding the optimal use of albumin in various clinical scenarios. It reviews recent studies and trials, highlighting the need for refined dosing and administration strategies to maximize patient outcomes while minimizing risks.
No account needed